Medication Management / Assessments
At RECO Immersive, medication management is a board-certified psychiatrist, your pharmacogenomic profile, and your qEEG findings — combined into a precision pharmacology plan. We start with how your liver metabolizes each drug class (CYP2D6, CYP2C19, CYP3A4) before choosing an agent, eliminating the trial-and-error that wastes weeks on a medication your genome can't process well.
The "right medication" for major depression, bipolar II, generalized anxiety, OCD, ADHD, or PTSD looks different in every patient. SSRIs vs SNRIs vs atypical antipsychotics vs mood stabilizers — the call is driven by symptom cluster, prior response history, side-effect tolerability, and the genetic and EEG data we collect at intake. That precision is the difference between feeling better in 4 weeks and another year of cycling through prescriptions.
Medication is one leg of integrated psychiatric care, alongside CBT/DBT/EMDR, TMS, neurofeedback, and IV nutrient therapy. We coordinate the prescription with the psychotherapy, monitor symptom response with PHQ-9, GAD-7, and qEEG re-tests every 4-6 weeks, and titrate doses upward, downward, or off completely once stable. The endpoint is the lowest effective dose — sometimes zero.
Medication management questions, answered
What conditions does psychiatric medication management treat?
Medication management at RECO Immersive supports treatment for major depressive disorder, generalized and panic anxiety, bipolar I and II, OCD, ADHD, PTSD, and select sleep and substance-related conditions. Each prescription is tied to a specific DSM-5 diagnosis, symptom inventory baseline, and treatment goal — never written without a clear clinical target.
How does pharmacogenomic testing improve medication selection?
Pharmacogenomic testing analyzes how your liver enzymes (CYP2D6, CYP2C19, CYP3A4) metabolize psychiatric medications. The result tells your psychiatrist which SSRIs, SNRIs, mood stabilizers, or atypical antipsychotics your genome processes efficiently — and which to avoid. This eliminates weeks or months of trial-and-error trying a drug your body cannot metabolize well.
How long until I will know if a medication is working?
SSRIs and SNRIs typically show partial response in 2 to 4 weeks and full response by 6 to 8 weeks. Mood stabilizers and atypical antipsychotics often respond faster (1 to 3 weeks). At RECO Immersive, we re-administer PHQ-9, GAD-7, or PCL-5 every 2 weeks to track quantitative response and adjust dose, switch, or augment when the data calls for it.
Will I have to be on psychiatric medication forever?
For most patients, no. Roughly half of major depressive episodes resolve within 6 to 12 months and medication can be tapered. Recurrent or chronic conditions (bipolar I, schizoaffective, severe OCD) often benefit from long-term maintenance. We re-evaluate every 3 to 6 months and aim for the lowest effective dose — sometimes zero — once stable.
How does RECO Immersive handle medication side effects?
Side effect tracking is part of every visit: sleep, appetite, sexual function, GI, weight, cognitive blunting, akathisia, and any new symptoms. Most are dose-dependent and respond to titration. Persistent or intolerable side effects trigger a switch — often informed by your pharmacogenomic profile. Patients are never told to 'just push through' an adverse effect.
Does insurance cover psychiatric medication management?
Yes. Psychiatric medication management is covered by all major commercial insurance plans — Aetna, BlueCross BlueShield, Cigna, United, Optum, Magellan, Humana — under standard E&M and psychiatric CPT codes (99213-99215, 90792, 90833). Pharmacogenomic testing is also reimbursable in most cases when ordered for treatment-resistant depression.
